HRV Pharma to acquire German firm Phatebo
In short
HRV Pharma will buy German firm Phatebo. The deal is meant to move the company beyond active pharmaceutical ingredients and into finished medicines.
It also gives HRV Pharma a licensed operating business in Germany.
What the reporting says
HRV Pharma will acquire German firm Phatebo, and the deal is described as a move beyond active pharmaceutical ingredients into finished formulations. The acquisition is also said to give HRV Pharma a licensed operating business in Germany.
Why it matters
HRV Pharma will acquire German firm Phatebo, a move that is said to take it beyond active pharmaceutical ingredients into finished formulations. The deal also gives the company a licensed operating business in Germany.